Protective Flu Vaccine Candidate Clears Early Human Test.

Fierce Vaccines (10/9, Liu) reports that FluGen’s a novel vaccine that prevents multiple strains of flu, RedeeFlu, was found to be “safe and well-tolerated” in an early-phase human trial involving 96 adults. The company is also working with NIH’s Nationa...